News and Opinion - Page 16 of 16 - IPHA

News and Opinion

October 16, 2018

Pharmacists key to driving a self care strategy

Pharmacists and pharmaceutical industry partner in major Self Care awareness campaign: ‘Be Well this Winter – Think Pharmacy’, to promote a focused approach to better patient […]
October 12, 2018

Industry presses to protect IP Incentives

IPHA is pressing the Irish Government and our MEPs to protect the IP incentives regime which is in danger of erosion by proposed legislation in Brussels. […]
October 9, 2018

Sharp Rise in Health Budget But Patients Still Left Waiting For Innovative Medicines – IPHA

As the Government announced the Budget today [Wednesday], the Irish Pharmaceutical Healthcare Association (IPHA) has said it was very disappointing that enough money could not be […]
September 12, 2018

New President at IPHA

Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA). In this position, […]
August 10, 2018

New Report Backs Biopharma Innovation as Enabler for New Treatments, Jobs and Investments, says IPHA

Protecting Ireland’s innovation policy environment is key to developing new medicines for patients, and to attracting fresh investments in pharmaceutical manufacturing and research, according to a […]
August 9, 2018


Seven new cancer medicines available in 12 EU countries – but not yet in Ireland Persistent delays approving medicines at odds with Government’s cancer outcomes targets […]
July 2, 2018

Biopharma Industry’s Latest Price Drops Save €15m on Government’s Medicines Bill, says IPHA

Agreement with Government delivers more savings than forecast – but approvals process for medicines remains slow and inefficient Price reductions take effect for 750 packs of […]
June 22, 2018

IPHA Urges Progress on Access to Medicines as Ireland Signs Up to BeNeLuxA

As Ireland signed up today [Friday] to the BeNeLuxA Initiative on pricing and supply of innovative medicines, the Irish Pharmaceutical Healthcare Association (IPHA) has said the […]